Authors: Meeuwisse-Pasterkamp, Susanne H; van der Klauw, Melanie M; Wolffenbuttel, Bruce HR

Source: Expert Review of Cardiovascular Therapy, Volume 6, Number 3, March 2008 , pp. 323-341(19)

Publisher: Expert Reviews

Abstract:

Type 2 diabetes mellitus is a disease that affects a rapidly increasing number of patients. Most patients with Type 2 diabetes will develop vascular complications. This may be microvascular disease, such as nephropathy, retinopathy or polyneuropathy, and also macrovascular disease, such as coronary heart disease, stroke or peripheral artery disease. Optimal control of elevated blood glucose levels will reduce the symptoms of hyperglycemia and help to prevent the development of complications. In addition, treatment of hypertension and lipid disturbances has been shown to reduce the incidence and severity of vascular complications significantly. The current treatment goals focus on adequate and aggressive treatment of these three risk factors. The central dogma for treatment of blood glucose, blood pressure and cholesterol levels is the lower the better. Ongoing trials evaluate the effect of further lowering these treatment goals and of specific types of medication on cardiovascular events.

Keywords: aspirin; dyslipidemia; hyperglycemia; hypertension; Type 2 diabetes; vascular complications

Document Type: Research article

DOI: http://dx.doi.org/10.1586/14779072.6.3.323

Affiliations: 1: InternistEndocrinologist, Department of Endocrinology & Metabolism, University Medical Center Groningen, PO Box 30.001, 9700 RB Groningen, The Netherlands., Email: s.h.meeuwisse@int.umcg.nl

Publication date: 2008-03-01

More about this publication?

• Expert Review of Cardiovascular Therapy provides expert commentary on the clinical applications of the new medicines, therapeutic agents and diagnostics in cardiovascular disease. Coverage inculdes drug therapy, heart disease, vascular disorders, hypertension, cholesterol in cardiovascular disease, heart disease, stroke, heart failure and cardiovascular surgery.
• Editorial Board
• Information for Authors
• Submit a Paper
• Subscribe to this Title
• Information for Advertisers
• Terms & Conditions
• Information for Librarians
• Free Trials
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Cardiovascular Medicine ,  Pharmacology
• By this author: Meeuwisse-Pasterkamp, Susanne H ;  van der Klauw, Melanie M ;  Wolffenbuttel, Bruce HR

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers